
Reta-Peptide
BPC-157
Finnrick tested 8 samples of BPC-157 (Bepecin) from Reta-Peptide between 16 Jul 2025 and 6 Dec 2025. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).
Finnrick Rating™
Reta-Peptide
BPC-157
Tested 8 Samples
Last test 6 Dec 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other BPC-157 tests from top-rated vendors:
All BPC-157 tests from Reta-Peptide
Samples are tested in commercial labs
Tests Count
8
Scores
AVGMINMAX
Last
6 Dec 2025
First
16 Jul 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 6 Dec 2025 | View | 10mg | 10.8mg | +8.0% | 99.75% | November 5, 2025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 25 Nov 2025 | View | 5mg | 4.11mg | -17.8% | 99.47% | (no batch ID) | No Label / Silver Crimp / Clear Red Cap | Lab E | Public | |
| 17 Nov 2025 | View | 10mg | 10.6mg | +6.0% | 99.58% | September 6, 2025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 24 Oct 2025 | View | 10mg | 9.1mg | -9.0% | 99.70% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |
| 23 Oct 2025 | View | 10mg | ⚠️ Sample does not contain BPC-157 | September 6, 2025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |||
| 14 Oct 2025 | View | 5mg | 5.4mg | +8.0% | 99.70% | AUG 15, 2025 | No Label / Silver Crimp / Clear Red Cap | Lab G | Public | |
| 4 Aug 2025 | View | 5mg | 4.89mg | -2.2% | 97.37% | June 2, 2025 | No Label / Silver Crimp / Clear Red Cap | Lab E | Public | |
| 16 Jul 2025 | View | 10mg | 11.54mg | +15.4% | 98.82% | (no batch ID) | White Label / Silver Crimp / Clear Blue Cap | Lab F | Public | |